Dysregulation of Amino Acid Metabolism in Diabetic Kidney Disease: Pathogenic Mechanisms and Emerging Therapeutic Strategies
Journal of Diabetes · 2026-11 · 18 (11)
DOI: 10.1111/1753-0407.70291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 20.11.2026. Verfasst von Simiao Guo und 11 weiteren Autor:innen. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is among the most serious microvascular complications associated with diabetes mellitus (DM). Approximately 30% to 40% of people with DM develop DKD. Although the current combination of hypoglycemic drugs and tight blood pressure management can delay the progression of renal function deterioration, it is still unable to effectively prevent the progression of kidney failure. Emerging evidence highlights the significance of dysregulation of amino acid metabolism in the pathogenesis of DKD, which is strongly linked to multiple pathological processes, including oxidative stress, inflammatory response, epithelial‐mesenchymal transition, mitochondrial dysfunction, and ferroptosis. This review systematically discusses the interaction between abnormal amino acid metabolism and the progression of DKD. It comprehensively summarizes the main molecular pathways of amino acid metabolism disorders mediating the progression of DKD through podocytes, renal tubular epithelial cells, and glomerular endothelial cells. It also focuses on the latest research progress on the target cell‐specific amino acid metabolic reprogramming in DKD. These findings enhance our understanding of the impact of DKD on amino acid metabolism, provide a new perspective on the pathogenesis of DKD, explore the possibility of treating DKD by correcting amino acid metabolism disorders, and provide new ideas and methods for the early detection and clinical management of DKD.
Zitieren
APA
Guo, S., Zhao, J., Zheng, Q., Wang, A., Han, M., Hui, Y., Xu, R., Qiao, Y., Liu, Y., Jiang, M., Ning, X., & Sun, S. (2026). Dysregulation of Amino Acid Metabolism in Diabetic Kidney Disease: Pathogenic Mechanisms and Emerging Therapeutic Strategies. Journal of Diabetes, 18(11). https://doi.org/10.1111/1753-0407.70291
Vancouver
Guo S, Zhao J, Zheng Q, Wang A, Han M, Hui Y, et al. Dysregulation of Amino Acid Metabolism in Diabetic Kidney Disease: Pathogenic Mechanisms and Emerging Therapeutic Strategies. Journal of Diabetes. 2026;18(11). doi:10.1111/1753-0407.70291
BibTeX
@article{Guo2026,
author = {Guo, Simiao and Zhao, Jin and Zheng, Qiao and Wang, Anjing and Han, Mei and Hui, Yueqing and Xu, Ruotong and Qiao, Yifan and Liu, Yichen and Jiang, Mingwei and Ning, Xiaoxuan and Sun, Shiren},
title = {Dysregulation of Amino Acid Metabolism in Diabetic Kidney Disease: Pathogenic Mechanisms and Emerging Therapeutic Strategies},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {11},
doi = {10.1111/1753-0407.70291}
}
EUVIMED